Intuitive Surgical Inc (ISRG) EVP & Chief Medical Officer Myriam Curet Sells Company Shares
Intuitive Surgical Inc (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has reported an insider sale according to a recent SEC filing. EVP & Chief Medical Officer Myriam Curet has sold 1,605 shares of the company on March 1, 2024.Myriam Curet has been actively trading shares over the past year, with a total of 25,689 shares sold and no shares purchased. This latest transaction continues the trend of insider sales at Intuitive Surgical Inc, with a total of 34 insider sells and no insider buys over the past year.
On the date of the insider's recent sale, shares of Intuitive Surgical Inc were trading at $383.48, giving the company a market capitalization of $140.197 billion. The price-earnings ratio of the company stands at 79.11, which is above both the industry median of 27.855 and the historical median price-earnings ratio for Intuitive Surgical Inc.The stock's valuation, as per the GuruFocus Value, is at $355.68, indicating that with a price-to-GF-Value ratio of 1.08, Intuitive Surgical Inc is considered modestly overvalued.
The GF Value is a proprietary intrinsic value estimate from GuruFocus, which takes into account historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates from Morningstar analysts.The recent insider sale by EVP & Chief Medical Officer Myriam Curet provides investors with information on insider sentiment and may be a factor to consider in their investment decisions regarding Intuitive Surgical Inc (NASDAQ:ISRG).
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
